Physician profile
Bradley A Levitt
NPI 1295006575
$242,562.73
in general payments reported to CMS, 2019-2025
37 companies · $93K in 2025
The $93K reported for 2025 was more than what 99% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,014 · 2020: $645 · 2021: $29K · 2022: $6,379 · 2023: $39K · 2024: $67K · 2025: $93K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $122K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $35K · Travel and Lodging: $32K · Food and Beverage: $9,583.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $121,895.02 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $35,324.50 |
| Travel and Lodging | $32,281.29 |
| Food and Beverage | $9,582.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $106,287.96 | 2019-2025 | Truelok, Oscar Pro, Truelok System |
| Access Pro Medical, LLC | $67,372.31 | 2025 | Matriderm |
| Stryker Corporation | $34,631.30 | 2019-2025 | Hoffmann, T2, Variax |
| Medical Device Business Services, INC. | $20,898.19 | 2019-2024 | Na |
| Integra Lifesciences Corporation | $4,032.69 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Bone Support INC. | $3,152.42 | 2025 | Cerament G, Ceramentbone Void Filler |
| Depuy Synthes Sales INC. | $1,159.18 | 2019-2025 | Na, Motoband, Hammerlock |
| Kerecis Limited | $778.45 | 2020-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Biotissue Holdings INC. | $638.20 | 2022 | |
| Paragon 28, INC. | $559.49 | 2022-2025 | Portfolio, Monkey Rings, Additive Orthopedics |
| Bioventus LLC | $282.21 | 2021-2025 | Exogen Ultrasound Bone Healing System |
| Wright Medical Technology, INC. | $278.85 | 2019-2020 | |
| Globus Medical, INC. | $252.00 | 2024 | Precice Intramedullary Limb Lengthening System |
| Lifenet Health | $235.18 | 2023-2025 | Theragenesis Wound Matrix |
| Misonix INC | $215.43 | 2019-2021 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fortis Surgical, LLC | $213.42 | 2023-2025 | |
| Polynovo North America LLC | $209.74 | 2024 | Novosorb Btm |
| Linvatec Corporation | $189.78 | 2024-2025 | Biobrace 23mm, Colink Vallux, Hercules Suture Anchor System |
| Biocomposites INC | $149.41 | 2023 | Stimulan |
| Sanara Medtech INC. | $149.30 | 2023 | Celleraterx |
| Convatec INC. | $148.75 | 2024 | |
| Trice Medical, INC. | $130.14 | 2025 | |
| Horizon Therapeutics Plc | $119.46 | 2022 | |
| Innovation Technologies INC | $110.00 | 2025 | Irrisept |
| Treace Medical Concepts, INC. | $106.49 | 2025 | |
| Crossroads Extremity Systems, LLC | $36.87 | 2019 | |
| Novo Nordisk INC | $29.53 | 2024 | Ozempic, Rybelsus |
| Medtronic, INC. | $26.96 | 2024 | Intellis Adaptivestim |
| Biohaven Pharmaceutical Holding Company LTD. | $26.59 | 2022 | |
| Nevro Corp. | $23.40 | 2022 | |
| Teleflex LLC | $22.79 | 2023 | Quikclot |
| Abbvie INC. | $22.73 | 2021 | |
| Merck Sharp & Dohme LLC | $19.58 | 2023 | Dificid |
| Kyowa Kirin, INC. | $19.48 | 2024 | Crysvita |
| Solventum Corporation | $18.62 | 2024 | V.A.C. Granufoam, V.A.C. Dermatac |
| Smith+Nephew, INC. | $15.83 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Levitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.